Genotypes of European and Iranian patients with type 3 von Willebrand disease enrolled in 3WINTERS-IPS (vol 5, pg 2987, 2021)

被引：0
|
作者：
Baronciani, L.
Peake, I
Schneppenheim, R.
机构：
来源：
BLOOD ADVANCES | 2023年 / 7卷 / 02期
关键词：
D O I：
10.1182/bloodadvances.2022007113
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：235 / 235
页数：1
相关论文
共 50 条
  • [31] An evaluation of von Willebrand factor (recombinant) therapy for adult patients living with severe type 3 von Willebrand disease
    Hancock, John M.
    Escobar, Miguel A.
    EXPERT REVIEW OF HEMATOLOGY, 2023, 16 (03) : 157 - 161
  • [32] PROPHYLAXIS WITH RECOMBINANT VON WILLEBRAND FACTOR IN PATIENTS WITH TYPE 3 VON WILLEBRAND DISEASE: POST HOC ANALYSIS FROM A PHASE 3 TRIAL
    Leebeek, Frank W. G.
    Escobar, Miguel
    Tiede, Andreas
    Wang, Michael
    Zulfikar, Bulent
    Wang, Scarlett
    Wang, Yi
    Ozen, Gulden
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 : E63 - E63
  • [33] Prophylaxis with recombinant von Willebrand factor in patients with type 3 von Willebrand disease: Results of a post hoc analysis from a phase 3 trial
    Leebeek, Frank W. G.
    Peyvandi, Flora
    Tiede, Andreas
    Castaman, Giancarlo
    Escobar, Miguel
    Wang, Michael
    Zulfikar, Bulent
    Susen, Sophie
    Miesbach, Wolfgang
    Wang, Scarlett
    Wang, Yi
    Zhang, Jingmei
    Ozen, Gulden
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 111 (01) : 29 - 40
  • [34] Efficacy of emicizumab therapy in two adult patients with type 3 von Willebrand disease
    LeMaistre, Frederick Ian
    Chiang, Elaine
    Streiff, Michael B.
    Yui, Jennifer C.
    BLOOD COAGULATION & FIBRINOLYSIS, 2024, 35 (04) : 206 - 208
  • [35] Current Management of Patients with Severe von Willebrand Disease Type 3: A 2012 Update
    Federici, Augusto B.
    James, Paula
    ACTA HAEMATOLOGICA, 2012, 128 (02) : 88 - 99
  • [36] Phenotypic and molecular characterisation of type 3 von Willebrand disease in a cohort of Indian patients
    Ahmad, Firdos
    Budde, Ulrich
    Jan, Rifat
    Oyen, Florian
    Kannan, Meganathan
    Saxena, Renu
    Schneppenheim, Reinhard
    THROMBOSIS AND HAEMOSTASIS, 2013, 109 (04) : 652 - 660
  • [37] Molecular characterization of a multiethnic group of 21 patients with type 3 von Willebrand disease
    Baronciani, L
    Cozzi, G
    Canciani, MT
    Peyvandi, F
    Srivastava, A
    Federici, AB
    Mannucci, PM
    THROMBOSIS AND HAEMOSTASIS, 2000, 84 (04) : 536 - 540
  • [38] Genetic Heterogeneity in a Large Cohort of Indian Type 3 von Willebrand Disease Patients
    Kasatkar, Priyanka
    Shetty, Shrimati
    Ghosh, Kanjaksha
    PLOS ONE, 2014, 9 (03):
  • [39] Diagnosis and treatment of von Willebrand disease: new perspectives and nuances (vol 13, pg 3, 2007)
    Kessler, C. M.
    HAEMOPHILIA, 2008, 14 (03) : 669 - 669
  • [40] 3 DISTINCT CANDIDATE POINT MUTATIONS OF THE VON WILLEBRAND FACTOR GENE IN 4 PATIENTS WITH TYPE-IIA VON WILLEBRAND DISEASE
    SUGIURA, I
    MATSUSHITA, T
    TANIMOTO, M
    TAKAHASHI, I
    YAMAZAKI, T
    YAMAMOTO, K
    TAKAMATSU, J
    KAMIYA, T
    SAITO, H
    THROMBOSIS AND HAEMOSTASIS, 1992, 67 (06) : 612 - 617
12345